Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease

• Main Authors: Hongzhi Qiao (Author), Dong Fang (Author), Jing Chen (Author), Yuan Sun (Author), Chen Kang (Author), Liuqing Di (Author), Junsong Li (Author), Zhipeng Chen (Author), Jun Chen (Author), Yahan Gao (Author)
• Format: Book
• Published: Taylor & Francis Group, 2017-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Inflammatory bowel disease (IBD) such as Crohn's disease and ulcerative colitis is a chronic autoimmune disease affecting nearly five million people worldwide. Among all drug delivery system, oral administration is the most preferable route for colon-specific targeting and the treatment of IBD....